trattamento con mscs delle coin lesions di ginocchio dello sportivo
DESCRIPTION
TRATTAMENTO CON MSCS DELLE COIN LESIONS DI GINOCCHIO DELLO SPORTIVO. STEFANO ZANASI VILLA ERBOSA HOSPITAL GRUPPO SAN DONATO ORTHOPAEDICS DEPARTMENT IIIRD DIVISION – JOINT ARTHROPLASTY OPERATIVE CENTER CHIEF: STEFANO ZANASI M.D. Ther ’s high incidence of cartilage injuries in sport - PowerPoint PPT PresentationTRANSCRIPT
TRATTAMENTO CON MSCS DELLE COIN LESIONS
DI GINOCCHIO DELLO SPORTIVO
STEFANO ZANASIVILLA ERBOSA HOSPITAL
GRUPPO SAN DONATOORTHOPAEDICS DEPARTMENT
IIIRD DIVISION – JOINT ARTHROPLASTY OPERATIVE CENTERCHIEF: STEFANO ZANASI M.D.
Ther’s high incidence of cartilage injuries in sport
sports at greatest risk are linked to sudden direction changes with knee or ankle sprain
Football/soccerRugby
VolleyballBasket
Skitennis
Cartilage injury is due to - single trauma (sprain) or to
- overuse for repetitive microtraumatism in athletic gesture
Cartilage has limited self-repair capabilites
articular cartilage defects will ultimately result in chronic tissue losses
To contrast this relentless outcome new reconstructive techniques have been developed such
as 1. ACT
long-term results are encouragingbut present limitations
2. MSCs able to differentiate into chondral
and osseous lineages, thus able to fill the whole thickness of a defect and secrete some trophic molecules, which contribute of regeneration of damaged tissue, the final result being
cartilage on the top and bone on the bottom
MSCs
Costituiscono una popolazione residente nel midollo osseo di cellule adulte non
differenziate capace di autorigenerarsi e differenziarsi in cellule del tessuto adiposo, del tessuto cartilagineo, del tessuto osseo e
nello stroma che supporta l’ematopoiesi
CELLULE STAMINALI DI MIDOLLO OSSEO AUTOLOGO
CONCENTRATO BMAC
Si ottengono in soli 15 minuti partendo da midollo osseo aspirato da cresta iliaca (60 o 120 ml)
attraverso ciclo di centrifugazione operato da una centrifuga di piccole dimensioni, da usare in sala operatoria
senza necessità di personale specializzato.
La procedura elimina i globuli rossi e il prodotto finale contiene• Cellule staminali emopoietiche • Cellule staminali mesenchimali
• Progenitori vascolari • Cellule immunitarie e piastrine
• Fattori di crescita (attivazione con trombina autologa) in un volume finale di 10 o 20 ml
La procedura di concentrazione richiede l’utilizzo della centrifuga e del kit BMAC composto di due confezioni
(A) contiene il materiale utilizzato nel campo operatorio sterile per il prelievo del midollo da paziente
(B) contiene il materiale per la procedura di concentrazione dell’aspirato midollare
AB
Procedura• nella fase 1, si procede al prelievo del midollo da paziente, che viene raccolto
in una apposita sacca di sangue e infine trasferito in una siringa per essere passato all’esterno del campo sterile
nella fase 2, il campione di midollo viene immesso nella provetta, centrifugato, concentrato nel volume desiderato e di nuovo trasferito al campo operatorio
per il definitivo utilizzo mediante connessione di 2 siringhe diverse
METODI E MATERIALI
Sono stati inclusi in questo studio 40 pazienti sportivi di medio-alto livello
Affetti da lesione a stampo (>3 <9cm2)), III-IV stadio di Outerbridge interessanti CFM,CFL,rotula
Trattatidal 2/2009 al 2/2012 con impianto one step di MSCs da aspirato midollare
L’età media è stata di 32a (+/-9a).
Tutti i pazienti sono stati ricontrollati ad follow-up medio di 18mesi (8-36ms) .
La valutazione clinica è stata effettuata utilizzando il protocollo ICRS-IKDC;
la valutazione dell’impianto cartilagineo è stato effettuata con RMN ad 1.5T applicando il MOCART scoring system.
L’EuroQol EQ-5D è stato utilizzato per valutare la la qualità della vita dei pazienti.
Exemplificative case MSCs: PATELLA simple
Defect: coin lesionLocation: centro- medial area of LEFT/RIGHT patella
Size: 1.5 x 2.5 cm Patient: C. V., male, 28 ys. football playerSymptoms: Severe pain, locking, giving-way, recurrent effusionHistory: bilateral ACL reconstruction on summer of 2009 grafted CONCURRENTLY BILATERALLY on 21/06/2009,
2nd look arthroscopy at 12 ms.
C.V., male, 28 years old - grafted on 11/04/2009
C.V., male, 28 years old –grafted on 11/04/2009 : DX
C.V., male, 28 years old - grafted on 11/04/2009 : SN
Patient: C.V. Male, 28 years old
Arthroscopy Time:
12 months
Follow-up time: 12 months
IKDC Subjective Evaluation Score:
95.5 (improvement from baseline: 49.0)
Knee functional grade: Normal
ICRS Cartilage repair assessment:
12
C.V., male, 28 years old - grafted on 11/04/2009 2nd look at 12ms.f.up
C.V., male, 28 years old - grafted on 11/04/2009 2nd look at 12ms.f.up
RMN AT 12 MS
C.V., male, 28 years old - grafted on 11/04/2009 2nd look at 12ms.f.up - HYSTOLOGY
LIGHT STAINING FOR GAGS
LOW CONTENT AND NOT-UNIFORM DISTRIBUTION OF
TYPE II COLLAGEN
PRESENCE OF TYPE I COLLAGEN,
NOT CELL CLUSTERING AND COLUMNAR ORGANIZATION
DEMONSTRATES THE MATURATION OF IMPLANTED MSCS
TO A CLEAR FIBRO-HYALINE-LIKE PHENOTYPE WITHOUT PECULIAR CELL ORGANIZATION
Exemplificative case: MFC simpleC.D, male, 18 years old - grafted on 19/01/2002
Defect: coin lesionLocation: medial femoral condyleSize: 2 x 2.5 cmPatient: C.D., male, 21 years old. A1 male Serie football athlete Juvenile National Italian football team
History: grafted on 19/01/2002, NMR at 3, 6 and 9, 12 , 24 months post op
arthroscopic 2nd look on 12/01/2003
**
ARTHROSCOPIC ACI TECHNIQUE DEVELOPED
BY M. MARCACCI
C.D, male, 18 years old - grafted on 19/01/2002
C.D, male, 18 years old - grafted on 19/01/20022nd look artroscopy at 18 ms f.up
19/01/2002
Follow-up time: 18 months
Subjective Evaluation Score:97.5
(improvement from baseline: 49.0
Knee functional grade: Normal
Cartilage repair assessment: 12
In collaboration with: Prof. A. HOLLANDER, University of Bristol.
WELL-MATURED NEOCARTILAGE, WITH STRONG GLICOSAMINOGLYCANS
DEPOSITION.
STRONG COLLAGEN TYPE II DEPOSITION
COLUMNAR CHONDROCYTE
REARRANGEMENT INSIDE THE GRAFTED
TISSUE
C.D, male, 18 years old - grafted on 19/01/20022nd look artroscopy at 18 ms f.up
ACT VS MSCs: RESULTS two cohorts of 25 cases at 18 ms f.up
EuroQol (EQ-5D) (N=25 ACT VS 25 MSCs)
Statistically significant improvementsimilar for both groups (pain reduction) (Wilcoxon signed rank test: p<0.0001)
Statistically significant improvementin mobility similar for both groups
(Wilcoxon signed rank test: p<0.0001)
* Roset M et al. Sample size calculations in studies using EuroQol EQ5D. Quality of Life Research 8: 539-549, 1999
Pain/discomfort
Pre-opera-tively
MSCs ACT Reference population*
0
20
40
60
80
100
8.0
82.085.0
74.276
18 15 21.116
0 0 4.7
No pain or discomfort
Moderate pain or discomfort
Extreme pain or discomfort
% p
atie
nts
Mobility
Pre-opera-tively
MSCs ACT Reference population*
0
20
40
60
80
100
8.0
86.0 90.0 89.192
14 10 10.70 0 0 0.2
No mobility problems Some mobility problems
Confined to bed
% p
atie
nts
• Normal post-op without serious adverse events correlated to the graft
• 6/28 cases of increased temperature (<39°) completely ceased within 7 days
• clinical sympthoms (pain, effusion, catching, giving-way) significantly decreased within the 2nd month, and completely ceased, in all cases, within 3 months WITH GOOD/EXCELLENT JOINT FUNCTIONAL RECOVERY
• Significative improvement of ROM (flex-ext >15%):
average pre-op. active ROM 120° (range 80° - 140°)
average post-op active ROM 135° (range 110° - 140°)
SATISFACTORY CLINICAL RESULTS at 18 ms. average f. up
PRELIMINARY CONCLUSIONS: resurfacing by MSCs
Second look arthroscopy at 12 mo.:9/28
Significantly improved appearance of the tissue Total scaffold biodegradation
Complete and uniform fibrocartilagineous tissue resurfacing
discrete mechanical resistence to probe palpation Areas of uneven cartilage stiffness
PRELIMINARY CONCLUSIONS:
THE MATURATION OF IMPLANTED TISSUE ENGINEERED
CARTILAGE TO A CLEAR HYALINE-LIKE PHENOTYPE
WITH PECULIAR CELL ORGANIZATION
2nd look arthroscopy at 12 ms f. up: biopsy DEMONSTRATES
HIGH CONTENT AND UNIFORM
DISTRIBUTION OF TYPE II COLLAGEN
STRONG STAINING FOR GAGS
ABSENCE OF TYPE I COLLAGEN,
CELL CLUSTERING AND COLUMNAR ORGANIZATION
20x2.5x
THE MATURATION OF IMPLANTED MSCS
TO A CLEAR FIBRO-HYALINE-LIKE PHENOTYPE WITHOUT PECULIAR CELL ORGANIZATION
LIGHT STAINING FOR GAGS
LOW CONTENT AND NOT-UNIFORM DISTRIBUTION OF
TYPE II COLLAGEN
PRESENCE OF TYPE I COLLAGEN,
NOT CELL CLUSTERING AND COLUMNAR ORGANIZATION
Need to verify the results at 3 and 5 years to appreciate the
quality of the reconstructed tissueand the
Maintainance/IMPROVEMENT of the (FIBRO)cartilage quality (no degenerative changes?)
PRELIMINARY CONCLUSIONS: MSCs RECONSTRUCTION
In accordo con quanto scritto in Giannini S.,
“One-Step Bone Marrow-derived Cell Trasnsplantation in Talar Osteochondral Lesion”,
Clin. Orthop. Relat. Res. DOI 10.1007/s11999-009-0885-8 (Associaton of Bone and Joint Surgeons 2009).
Questo studio riporta che, in seguito a inoculo del concentrato di
midollo osseo su uno scaffold di acido ialuronico esterificato (HYAFF):
- non si osserva alcuna complicanza locale nè sistemica - si ha la riformazione di tessuto cartilagineo in modo del tutto sovrapponibile alla consolidata tecnica del trapianto di condrociti autologhi.- in un unico tempo operatorio, senza necessità di prelievo di
cartilagine e clonazione della stessa in centro di coltura specializzato con reimpianto successivo dopo circa 30 gg
- Significativo minor costo della procedura
Although longer followup is needed to confirm the validity of the repair overtime, the arthroscopic one-step technique represents an advance in osteochondral regeneration, achieving high clinical scores with the formation of repair tissue
and without the major disadvantages of previous techniques.
MSCs cartilage defect </= 4
cm2simple
shouldered
ACT
cartilage defect> 4cm2 Simple wide, Shouldered
Complex-salvageto delay implant arthroplasty
Long term Validated resultsShort term Evaluating results
Good functional/clinical resultsGood (?) % of hyaline tissue
duration?
Good functional/clinical resultsGood % of hyaline tissue
14 yrs f.up
EXCELLENT INTEGRATION OF THE NEOFORMED TISSUE WITH THE SUBCHONDRAL BONE.
THE TYDE-MARK IS DEVELOPING
C.D, male, 18 years old - grafted on 19/01/20022nd look artroscopy at 18 ms f.up
MSCs : 56 pts. from 02/09 to 02/12 for chondral knee defects Outerbridge stage III/IV
according to Tom Minas’ classification
simple 32/56 26 sportmen coin defect (troclea, patellar, condyle/s, emi-tibial plate)
complex 11/56 5 sportmenshouldered massive unipolar defect of the lateral/medial condyle
plurifocal not kissed and differently combined/spared coin defects (troclea, patellar, condyle/s, emi-tibial plate)
salvage 13/56 11 sportmenshouldered, limited kissing lesions not requiring realignment procedure
unshouldered kissing lesions and uni-compartmental OA concurrently with unloading/corrective osteotomy
32/56 sportmen
average age 25 ys (range 19 - 50) - 47% F
average defect size 3.5 cm2 (range 2.5 – 12.5cm)